随机对照试验的亚组分析缺乏合理依据且报告不充分
该研究评估随机对照试验方案中计划及后续发表中报告的亚组分析的适当性与依据,检索PubMed纳入2006-2017年发表的479份试验方案及对应的280篇试验发表。结果显示亚组分析在方案和发表中报告率低、预设不足、依据罕见,规范性与报告质量仍存在明显问题。
要点
- 仅19%的方案预设亚组分析,21%的试验发表报告了亚组分析。
- 56%的含亚组分析发表未预设亚组分析,仅4份方案和7篇发表提供依据。
- 亚组分析报告常不足以评估亚组效应跨研究的一致性。
核心结论
- 随机对照试验方案和发表中亚组分析的规范制定与报告仍存在问题。
- 亚组分析的依据或理由在试验方案和发表中仅罕见提供。
研究设计与样本
- 检索PubMed识别2006-2017年期间在期刊上发表的试验方案。
- 从最初识别的3774条记录中随机抽取479份方案,并匹配到280篇对应的试验发表。
主要发现
- 19%的方案预设了亚组分析,21%的试验发表报告了亚组分析。
- 94份有预设亚组分析的方案中,32%提及交互作用检验,仅3份考虑统计效能。
- 59篇含亚组分析的试验发表中,56%未预设亚组分析。
- 9篇试验发表声称亚组分析为预设,但无对应方案证据支持。
- 仅4份试验方案和7篇试验发表提供了亚组分析依据。
临床怎么用
- 设计随机对照试验时应预先明确亚组分析并说明依据及统计效能考虑。
- 报告亚组分析时应提供方案预设证据并充分报告以评估亚组效应一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of the article was to assess the appropriateness and rationales of subgroup analyses planned in protocols of randomized controlled trials and reported in subsequent corresponding trial publications. STUDY DESIGN AND SETTING: We searched PubMed to identify trial protocols published in journals during 2006-2017. From a total of 3,774 initially identified records, we included a random sample of 479 protocols and identified 280 trial publications corresponding to the included protocols. RESULTS: Subgroup analyses were specified in 19% of the protocols and reported in 21% of the trial publications. Of the 94 protocols with planned subgroup analyses, 32% mentioned testing for interaction, and only three considered statistical power. Subgroup analyses were not prespecified in 56% of the 59 trial publications with subgroup analyses. Subgroup analyses were stated as prespecified in nine trial publications, without support evidence from the corresponding protocols. Subgroup analyses were often reported insufficiently for assessing the consistency of subgroup effects across studies. Justifications for subgroup analyses were provided in only four trial protocols and seven trial publications. CONCLUSION: Inappropriate specification and reporting of subgroup analyses remain problematic in protocols and reports of randomized controlled trials. Justifications or rationales for subgroup analyses were only rarely provided in trial protocols and reports.
引用
- Fan J, Song F, Bachmann MO, et al. Justification and reporting of subgroup analyses were lacking or inadequate in randomized controlled trials. J Clin Epidemiol. 2018. PMID: 30557676. doi:10.1016/j.jclinepi.2018.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。